Dr. Reddy's launches generic semaglutide in Canada
Published October 26, 2026. News from May 16, 2026, as reported by Business Standard (company sourced) and Epocrates, cited below.
Quick take: Dr. Reddy's says it launched a generic semaglutide injection in Canada after receiving a Notice of Compliance on April 28, 2026. It is a prescription drug for adults with type 2 diabetes.
What was reported
| Item | Detail |
|---|---|
| Approval | Notice of Compliance from Health Canada, April 28, 2026 |
| Use | Once-weekly injection for adults with type 2 diabetes |
| Pens | 2 mg pen (0.25 mg or 0.5 mg doses) and 4 mg pen (1 mg doses) |
| Price | Not stated for this product |
| Pending | Eight more generic semaglutide applications under review in Canada, per Epocrates |
What it is not
- It is an authorized prescription drug, with a Health Canada review behind it.
- It is not a research peptide, and it is not related to research-use products.
- In the US, no generic semaglutide is FDA approved, per Epocrates.
Related: the approval story, the patent lapse and how approval works.
Reality check: the launch claim comes from the company. Prices vary, and this is not medical advice. Talk to a pharmacist or doctor about prescriptions.
Ready to order?
MOVRA10
Copy code and open Growth Guys
Paste it in the Promo code box in the order summary at checkout, then press Apply. Confirm the discount line before you pay.
Common questions
Who launched generic semaglutide in Canada?
Dr. Reddy's Laboratories, per its own announcement.
Which pen strengths were reported?
A 2 mg pen and a 4 mg pen.
Is it available in the US?
No FDA-approved generic semaglutide exists, per Epocrates.
Sources
- Business Standard: Dr. Reddy's launches generic semaglutide injection in Canada (May 16, 2026, company sourced)
- Epocrates: Generic semaglutide injection wins approval in Canada (Apr 30, 2026)
Summarised in my own words. Read the originals for the full detail.